Impact of Preoperative Dental Screening in Reducing Infective Endocarditis Risk in Transcatheter Aortic Valve Implantation Patients
Launched by ODENSE UNIVERSITY HOSPITAL · Mar 19, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how changes in dental screening before heart valve surgery (called Transcatheter Aortic Valve Implantation or TAVI) might affect the risk of a serious heart infection known as infective endocarditis. The researchers at Odense University Hospital are comparing the rates of this infection in patients who had mandatory dental checks before their surgery to those who had targeted dental checks after the protocol was changed. The goal is to understand if the new approach makes a difference in preventing infections.
If you are between the ages of 65 and 74 and are scheduled to undergo TAVI, you may be eligible to participate in this trial. There are no specific exclusion criteria, meaning that almost anyone having the procedure can join. As a participant, you will be part of a study that helps researchers learn more about the importance of dental health before heart surgery. This could potentially help improve safety and outcomes for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing TAVI
- Exclusion Criteria:
- • None
About Odense University Hospital
Odense University Hospital is a leading academic medical center located in Denmark, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital is committed to enhancing patient outcomes and fostering collaboration among multidisciplinary teams. With a focus on translating scientific discoveries into practical applications, Odense University Hospital leverages its state-of-the-art facilities and expertise to conduct rigorous trials across various medical fields, ensuring adherence to the highest ethical and regulatory standards. Through these efforts, the hospital aims to contribute significantly to the global body of medical knowledge and improve the quality of care for patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Odense, , Denmark
Patients applied
Trial Officials
Jordi S Dahl, MD,PhD,DMSc
Principal Investigator
Odense University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported